100% Secure Payments
Tender Details
- Country: USA
- Summary: Ondansetron HCL Tablets
- UST Ref No: 121108418
- Deadline: 18 Aug 2025
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: Public
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: SPE2D2-25-R-0017
- Purchaser's Detail :
- Description :
- Description
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Ondansetron Hydrochloride (HCL) Tablets. Procurement details follow.
Ondansetron Hydrochloride (HCL) 4 MG Tablet in 30, 100, and 500 count bottles.
Ondansetron Hydrochloride (HCL) 8 MG Tablet in 30 and 500 count bottles.
This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Kyle Lewicki at (445) 737-0977, (kyle.lewicki@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is July of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
*Originally, this requirement included Ondansetron 4MG Orally Dissolving Tablets (ODT) in 30 count bottles and 8MG ODTs in 10 and 30 count bottles. The ODT tablets will be solicited in a separate acquisition. - Documents :
Purchaser : DEPT OF DEFENSE | DEFENSE LOGISTICS AGENCY
MEDICAL SUPPLY CHAIN FSGB 700 ROBBINS AVENUE, PHILADELPHIA , PA 19111, USA
Primary Point of Contact: Kyle Lewicki, kyle.lewicki@dla.mil, Phone Number 4457370977
Secondary Point of Contact: Catherine Gilbert, catherine.gilbert@dla.mil, Phone N...
Email :kyle.lewicki@dla.mil
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
